🧬mRNA Therapeutics
Messenger RNA technology for vaccines and therapeutics — the platform behind COVID vaccines, now expanding to cancer and rare diseases.
Market Cap$292.9B
1D-1.69%
Companies33
Public Cos6
SECTOR MARKET CAP
$292.9B+2667.7%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $147.6B | PFE |
| 2 |  | United Kingdom | $100.7B | GSK |
| 3 |  | Germany | $23.6B | BNTX |
| 4 |  | United States | $20.4B | MRNA |
| 5 |  | United States | $581.1M | MRVI |
| 6 |  | United States | $9.2M | ERNA |